1. Home
  2. ACTG vs MYGN Comparison

ACTG vs MYGN Comparison

Compare ACTG & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acacia Research Corporation (Acacia Tech)

ACTG

Acacia Research Corporation (Acacia Tech)

HOLD

Current Price

$4.27

Market Cap

440.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.17

Market Cap

372.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACTG
MYGN
Founded
1993
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.1M
372.1M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
ACTG
MYGN
Price
$4.27
$4.17
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$6.00
★ $7.64
AVG Volume (30 Days)
167.8K
★ 2.0M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 161.11
N/A
EPS
★ N/A
N/A
Revenue
$12,004,000.00
★ $771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$3.15
$2.74
52 Week High
$5.27
$8.59

Technical Indicators

Market Signals
Indicator
ACTG
MYGN
Relative Strength Index (RSI) 31.22 63.78
Support Level $3.86 $2.89
Resistance Level $4.30 $4.79
Average True Range (ATR) 0.11 0.26
MACD -0.03 0.10
Stochastic Oscillator 13.16 92.47

Price Performance

Historical Comparison
ACTG
MYGN

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. It derives revenue from the Intellectual Property Operations segment. Geographically, it operates in the Americas, Europe, the Middle East and Africa, China, India, and Asia-Pacific.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: